Pabrai Investments reported 4 stock positions worth $326.7M in its 2026 Q2 Form 13F, for the quarter ended Jun 30, 2026, filed Aug 13, 2026. Its largest position is WARRIOR MET COAL, INC. (HCC), at 43.32% of the reported portfolio value. Its biggest move versus the previous quarter was in Alpha Metallurgical Resources, Inc. (AMR), where it cut the position by 10.8%.
Mohnish Pabrai founded Pabrai Investment Funds in 1999 in Irvine, California, and runs it as a disciple of Warren Buffett and Charlie Munger. His book, The Dhandho Investor, sets out the approach: buy a handful of wonderful businesses at deep discounts to what they are worth, hold them for years, and let compounding do the work. The portfolio is deliberately tiny and turnover is low, so each position carries real weight and a single decision can define a year.
The fund's 2026 Q2 Form 13F, for the quarter ended June 30, 2026 and filed August 13, 2026, reported just 4 stock positions worth $326.7 million. Warrior Met Coal (HCC) was the largest at 43.32% of the reported value, with 1,744,050 shares, trimmed 3.7% from the prior quarter. Transocean (RIG) followed at 30.53%, with 20,398,659 shares held unchanged, and Alpha Metallurgical Resources (AMR) at 26.11%, with 517,194 shares trimmed 10.8%. The only other holding was a small new stake in Kaspi.kz (KSPI), an ADR, at 0.05% with 1,702 shares.
Three coal and energy names make up almost the entire book, so this is concentration taken to an extreme: the top three positions account for about 99.9% of the reported value. The quarter's story is one of modest trims in both coal holdings, no change in Transocean, and a token-sized new position in Kaspi.kz. As with every 13F, this is a snapshot at quarter-end only — it covers long positions in U.S.-listed securities, omits cash, shorts and derivatives, and was filed 44 days after the quarter ended.
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| HCC | WARRIOR MET COAL, INC. | 43.32% | 1,744,050 | TRIMMED (-3.7%) |
| RIG | Transocean Ltd. | 30.53% | 20,398,659 | HELD |
| AMR | Alpha Metallurgical Resources, Inc. | 26.11% | 517,194 | TRIMMED (-10.8%) |
| KSPI | Joint Stock Co Kaspi.kz · ADR | 0.05% | 1,702 | NEW |
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 13, 2026. CIK 0001549575. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only and report holdings as of quarter-end; each filing is due within 45 days after quarter-end, so the filing lag above is the gap between quarter-end and this filing’s date, and it varies by when the manager actually filed.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Hypothetical 13F-clone performance — not the fund’s actual returns. The clone holds the long U.S. equity positions disclosed in this manager’s Form 13F filings at their reported weights, rebalanced on filing dates, on dividend-adjusted prices. Full series and the filing-by-filing evidence dossier: 13F-clone profile.
A snapshot at quarter-end, not today’s portfolio: 13F filings arrive up to 45 days late, cover long positions only, and omit cash, shorts, and derivatives. Copying this list also means copying its timing, prices, and position sizes.
Read the original filings at SEC EDGAR.
Not investment advice. Filings are delayed and incomplete.
How we measure: Methodology · Track Record · Q3 2026 13F tracker.
See the same rule applied to every tracked fund, including this one: Follow a Fund — each quarter’s top 5 new and increased positions, bought at the close on the first trading day after the 13F deadline and held for a quarter, scored against SPY.
Compare overlap → Compare your own book against this fund and the other tracked funds.
Century Management · Track Record: how the signals scored · Compare overlap
One email a week: the week’s new filings and research. Subscribe free
← OrbiMed Advisors · Paradigm Biocapital Advisors →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.